行情

ARMP

ARMP

Armata Pharmaceuticals Inc
AMEX

实时行情|Nasdaq Last Sale

2.810
-0.080
-2.77%
休市 16:00 01/17 EST
开盘
2.900
昨收
2.890
最高
2.940
最低
2.810
成交量
1.37万
成交额
--
52周最高
6.23
52周最低
2.450
市值
2,791.54万
市盈率(TTM)
-0.7249
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ARMP 新闻

  • 英国央行行长称:全球经济正陷入“流动性陷阱”
  • 新浪美股.3小时前
  • 弹劾案审讯开始在即 民主党人、特朗普律师提交主张
  • 新浪财经.3小时前
  • 利比亚输油管线和谈前被关闭 或加剧石油供应中断
  • 新浪财经.4小时前
  • 使用同一"排名最低"供应商 波音777X重现MAX安全问题
  • 新浪美股.4小时前

更多

所属板块

生物技术和医学研究
-0.16%
制药与医学研究
+0.06%

热门股票

名称
价格
涨跌幅

ARMP 简况

Armata Pharmaceuticals, Inc., formerly AmpliPhi Biosciences Corporation, is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products. The Company is engaged in developing these phage product candidates using a discovery and development platform, which is designed for identification, characterization and manufacturing of multiple phage therapies. Each product candidate combines several chosen phages, which target a specific disease-causing bacterial pathogen, such as staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa) and clostridium difficile (C. difficile). Its product candidates are AB-SA01 and AB-PA01.
展开

Webull提供Armata Pharmaceuticals Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。